ArticleAnnals of translational medicine2019

Osimertinib and dihydroartemisinin: a novel drug combination targeting head and neck squamous cell carcinoma.

Imane Chaib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.